Inspire Medical Systems, Inc.: D. E. SHAW & CO, L.P. amends Schedule 13G stake filing
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
D. E. Shaw & Co. amended its Schedule 13G filing for Inspire Medical Systems, disclosing a revised passive stake in the medical device maker under SEC accession 0001104659-26-128324. The filing updates the hedge fund's previously reported position in Inspire, which develops neurostimulation devices for sleep apnea. The specific size and direction of the stake change were not detailed in the headline disclosure. Investors watch 13G amendments for signals about institutional sentiment toward the company.
Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.
Named in this story
D. E. Shaw & Co., L.P., Inspire Medical Systems, Inc.